Improving our model of cascade testing for hereditary cancer risk by leveraging patient peer support: a concept report

[1]  M. Krawczyk,et al.  Evidence from a Systematic Review and Meta-Analysis Pointing to the Antidiabetic Effect of Polyphenol-Rich Plant Extracts from Gymnema montanum, Momordica charantia and Moringa oleifera , 2022, Current issues in molecular biology.

[2]  W. Chung,et al.  Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG) , 2021, Genetics in Medicine.

[3]  Christian Appenzeller‐Herzog,et al.  Interventions Facilitating Family Communication of Genetic Testing Results and Cascade Screening in Hereditary Breast/Ovarian Cancer or Lynch Syndrome: A Systematic Review and Meta-Analysis , 2021, Cancers.

[4]  B. Arun,et al.  Disclosure of familial implications of pathogenic variants in breast-cancer genes to patients: Opportunity for prompting family communication , 2021, Journal of Community Genetics.

[5]  S. Fullerton,et al.  What improves the likelihood of people receiving genetic test results communicating to their families about genetic risk? , 2021, Patient education and counseling.

[6]  T. Pal,et al.  Sharing genetic test results with family members of BRCA, PALB2, CHEK2, and ATM carriers. , 2021, Patient education and counseling.

[7]  D. Uyar,et al.  Challenges of Genomic Testing for Hereditary Breast and Ovarian Cancers , 2021, The application of clinical genetics.

[8]  Marianne Reid,et al.  Self-management in face-to-face peer support for adults with type 2 diabetes living in low- or middle-income countries: a systematic review , 2020, BMC Public Health.

[9]  Yuanyu Wu,et al.  Peer Support as an Ideal Solution for Racial/Ethnic Disparities in Colorectal Cancer Screening: Evidence from a Systematic Review and Meta-analysis , 2020, Diseases of the colon and rectum.

[10]  A. Kurian,et al.  Emerging Opportunity of Cascade Genetic Testing for Population-Wide Cancer Prevention and Control. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  A. Kurian,et al.  Health Disparities in Germline Genetic Testing for Cancer Susceptibility , 2020, Current Breast Cancer Reports.

[12]  K. Offit,et al.  Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  K. Offit,et al.  Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  S. Vernon,et al.  Assessing relatives’ readiness for hereditary cancer cascade genetic testing , 2019, Genetics in Medicine.

[15]  J. Jansz,et al.  With a Little Help from My Friends: Peer Coaching for Refugee Adolescents and the Role of Social Media , 2019, Media and Communication.

[16]  G. Mensah,et al.  Leveraging Implementation Science to Address Health Disparities in Genomic Medicine: Examples from the Field. , 2019, Ethnicity & disease.

[17]  M. Watson,et al.  Current conditions in medical genetics practice , 2019, Genetics in Medicine.

[18]  S. Kripalani,et al.  Precision Medicine: Familiarity, Perceived Health Drivers, and Genetic Testing Considerations Across Health Literacy Levels in a Diverse Sample , 2018, Journal of Genetic Counseling.

[19]  N. Islam,et al.  Applying a community-based participatory research framework to patient and family engagement in the development of patient-centered outcomes research and practice. , 2018, Translational behavioral medicine.

[20]  C. Isaacs,et al.  Information and support needs of young women regarding breast cancer risk and genetic testing: adapting effective interventions for a novel population , 2018, Familial Cancer.

[21]  D. Schillinger,et al.  Cancer genetic counseling communication with low-income Chinese immigrants , 2018, Journal of Community Genetics.

[22]  D. Bowen,et al.  Delivery Of Cascade Screening For Hereditary Conditions: A Scoping Review Of The Literature. , 2018, Health affairs.

[23]  G. D. de Bock,et al.  Severity and duration of menopausal symptoms after risk-reducing salpingo-oophorectomy. , 2018, Maturitas.

[24]  Aviad E. Raz,et al.  Familial communication and cascade testing among relatives of BRCA population screening participants , 2018, Genetics in Medicine.

[25]  N. Latham,et al.  Peer Coaching Through mHealth Targeting Physical Activity in People With Parkinson Disease: Feasibility Study , 2018, JMIR mHealth and uHealth.

[26]  C. Guerra,et al.  Cancer Counseling of Low-Income Limited English Proficient Latina Women Using Medical Interpreters: Implications for Shared Decision-Making , 2018, Journal of Genetic Counseling.

[27]  J. A. Oliveira,et al.  The Impact of mHealth Interventions: Systematic Review of Systematic Reviews , 2018, JMIR mHealth and uHealth.

[28]  E. Ratner,et al.  The management of sexuality, intimacy, and menopause symptoms (SIMS) after prophylactic bilateral salpingo-oophorectomy: How to maintain sexual health in "previvors". , 2017, Maturitas.

[29]  Y. Kuo,et al.  Use of BRCA Mutation Test in the U.S., 2004-2014. , 2017, American journal of preventive medicine.

[30]  Leah E. Mechanic,et al.  Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  D. Schillinger,et al.  Information Mismatch: Cancer Risk Counseling with Diverse Underserved Patients , 2017, Journal of Genetic Counseling.

[32]  W. Chung,et al.  Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics , 2016, Genetics in Medicine.

[33]  M. Dwyer,et al.  Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

[34]  C. Isaacs,et al.  Understanding the Needs of Young Women Regarding Breast Cancer Risk Assessment and Genetic Testing: Convergence and Divergence among Patient-Counselor Perceptions and the Promise of Peer Support , 2016, Healthcare.

[35]  E. Fisher,et al.  Peer Support for the Hardly Reached: A Systematic Review. , 2016, American journal of public health.

[36]  B. Peshkin,et al.  Genetic counseling and testing for hereditary cancer risk in young adult women: Facilitating autonomy and informed decision making is key , 2015, Gynecologic oncology reports.

[37]  S. Lincoln,et al.  Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment. , 2015, JAMA oncology.

[38]  T. Slavin,et al.  Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management , 2015, Front. Oncol..

[39]  E. Fisher,et al.  Key Features Of Peer Support In Chronic Disease Prevention And Management. , 2015, Health affairs.

[40]  Geoffrey B. Nilsen,et al.  A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients. , 2015, The Journal of molecular diagnostics : JMD.

[41]  J. West,et al.  Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer , 2015, Annals of Surgical Oncology.

[42]  Jonathan S Berg,et al.  Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents. , 2015, American journal of human genetics.

[43]  Andrea C. Johnson,et al.  Survey on Addressing the Information and Support Needs of Jewish Women at Increased Risk for or Diagnosed with Breast Cancer: The Sharsheret Experience , 2015, Healthcare.

[44]  A. Werner-Lin,et al.  A Survey of Genetic Counselors About the Needs of 18–25 Year Olds from Families with Hereditary Breast and Ovarian Cancer Syndrome , 2015, Journal of Genetic Counseling.

[45]  Carla L. Fisher,et al.  Talking About Familial Breast Cancer Risk , 2014, Qualitative health research.

[46]  A. Patenaude,et al.  Young adult daughters of BRCA1/2 positive mothers: What do they know about hereditary cancer and how much do they worry? , 2013, Psycho-oncology.

[47]  P. Butow,et al.  Distress in unaffected individuals who decline, delay or remain ineligible for genetic testing for hereditary diseases: a systematic review , 2013, Psycho-oncology.

[48]  S. Cummings,et al.  NSGC Practice Guideline: Risk Assessment and Genetic Counseling for Hereditary Breast and Ovarian Cancer , 2013, Journal of Genetic Counseling.

[49]  C. Isaacs,et al.  Long-Term Psychosocial Outcomes of BRCA1/BRCA2 Testing: Differences across Affected Status and Risk-Reducing Surgery Choice , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[50]  Y. Brandberg,et al.  Bilateral prophylactic mastectomy in women with inherited risk of breast cancer--prevalence of pain and discomfort, impact on sexuality, quality of life and feelings of regret two years after surgery. , 2010, Breast.

[51]  Craig D. Shriver,et al.  Breast Cancer in the Personal Genomics Era , 2010, Current genomics.

[52]  Rachel E. Goldsmith,et al.  Cognitive and emotional factors predicting decisional conflict among high-risk breast cancer survivors who receive uninformative BRCA1/2 results. , 2009, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[53]  A. Patenaude,et al.  Brief assessment of parents' attitudes toward testing minor children for hereditary breast/ovarian cancer genes: development and validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS). , 2009, Journal of pediatric psychology.

[54]  E. Weber,et al.  Affective and deliberative processes in risky choice: age differences in risk taking in the Columbia Card Task. , 2009, Journal of experimental psychology. Learning, memory, and cognition.

[55]  O. Olopade,et al.  How often do BRCA mutation carriers tell their young children of the family's risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  Giovanni Parmigiani,et al.  Meta-analysis of BRCA1 and BRCA2 penetrance. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  J. Klijn,et al.  Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study , 2006, Clinical genetics.

[58]  R. Eeles,et al.  Communication about genetic testing in families of male BRCA1/2 carriers and non‐carriers: patterns, priorities and problems , 2005, Clinical genetics.

[59]  Adopted on March.  American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[60]  J. Satagopan,et al.  Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[61]  C. Isaacs,et al.  Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  ACOG Committee Opinion No. 727 Summary: Cascade Testing: Testing Women For Known Hereditary Genetic Mutations Associated With Cancer. , 2018, Obstetrics and gynecology.

[63]  B. Karlan,et al.  Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions. , 2015, Gynecologic oncology.

[64]  W. Campbell,et al.  Examples from the field , 2011 .

[65]  J. Emery,et al.  Psychological Impact of Genetic Counseling for Familial Cancer: A Systematic Review and Meta-Analysis , 2005, Familial Cancer.

[66]  P. Barton,et al.  Screening for fragile X syndrome: a literature review and modelling study. , 2003, Health technology assessment.

[67]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[68]  B. Newman,et al.  Development Through Life: A Psychosocial Approach , 1979 .

[69]  Robert J. Havighurst,et al.  Developmental tasks and education , 1943 .

[70]  M. Best,et al.  ResearchOnline@ND ResearchOnline@ND , 2022 .